Welcome to LookChem.com Sign In|Join Free
  • or
3,5-bis(((tert-butyldimethylsilyl)oxy)methyl)-N-(2-(2-(2-methoxyethoxyl)ethoxy)ethyl)aniline is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1239588-01-2

Post Buying Request

1239588-01-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1239588-01-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1239588-01-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,3,9,5,8 and 8 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1239588-01:
(9*1)+(8*2)+(7*3)+(6*9)+(5*5)+(4*8)+(3*8)+(2*0)+(1*1)=182
182 % 10 = 2
So 1239588-01-2 is a valid CAS Registry Number.

1239588-01-2Downstream Products

1239588-01-2Relevant academic research and scientific papers

Cytotoxic benzodiazepine derivatives

-

Page/Page column 248, (2015/11/09)

The invention relates to novel benzodiazepine derivatives with antiproliferative activity and more specifically to novel benzodiazepine compounds of formula (I)-(VII). The invention also provides conjugates of the benzodiazepine compounds linked to a cell

NOVEL BENZODIAZEPINE DERIVATIVES

-

Page/Page column 231-232, (2010/08/18)

The invention relates to novel benzodiazepine derivatives with antiproliferative activity and more specifically to novel benzodiazepines of formula (I) and (II), in which the diazepine ring (B) is fused with a heterocyclic ring (CD), wherein the heterocyclic ring is bicyclic or a compound of formula (III), in which the diazepine ring (B) is fused with a heterocyclic ring (C), wherein the heterocyclic ring is monocyclic. The invention provides cytotoxic dimers of these compounds. The invention also provides conjugates of the monomers and the dimers. The invention further provides compositions and methods useful for inhibiting abnormal cell growth or treating a proliferative disorder in a mammal using the compounds or conjugates of the invention. The invention further relates to methods of using the compounds or conjugates for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1239588-01-2